As people grow older, their bodies go through many changes at the smallest level. Inside each cell, tiny changes in DNA slowly build up over time.
These changes are called mutations. Most of the time, they do not cause problems. But sometimes, they can affect how cells behave and may be linked to disease.
A new study from Boston Children’s Hospital has discovered something surprising about these mutations in the brain.
The research, published in the journal Cell, suggests that some of the same genetic changes that drive cancer may also play a role in Alzheimer’s disease. This finding offers a new way to think about how this common and serious brain condition develops.
Alzheimer’s disease is one of the leading causes of memory loss in older adults. It affects thinking, behavior, and the ability to carry out daily tasks.
Scientists have long known that abnormal proteins build up in the brains of people with Alzheimer’s. These protein clumps damage brain cells and lead to their death. However, the full cause of the disease is still not completely understood.
In this study, researchers focused on special cells in the brain called microglia. These cells act as the brain’s cleaning system. They remove waste, damaged cells, and harmful substances.
They also help protect the brain from infection and injury. Because of their important role, any change in how microglia behave could have a big impact on brain health.
The research team studied brain tissue from hundreds of people. They compared samples from individuals with Alzheimer’s disease to those from healthy individuals. They looked closely at 149 genes that are known to be involved in cancer.
The results showed that the brains of people with Alzheimer’s had more genetic changes in these cancer-related genes. In particular, five specific genes showed repeated mutations. This suggests that certain microglia cells may gain these mutations and then grow or spread more than others.
What makes this finding even more surprising is that these mutations did not lead to cancer in the brain. Instead, they seemed to change how microglia behave. The mutated cells may become more active or more aggressive, creating an environment that is harmful to nearby neurons.
The researchers also made another unexpected discovery. They found the same cancer-related mutations in the blood cells of the same patients. This suggests that some immune cells from the blood may be entering the brain.
Normally, the brain is protected by a barrier that prevents most blood cells from entering. This barrier is known as the blood-brain barrier. However, as people age or experience injury, this barrier may become weaker. When this happens, blood cells carrying these mutations may cross into the brain.
Once inside, these cells may take on roles similar to microglia. Because they carry cancer-like mutations, they may have an advantage over normal cells. They may multiply more quickly or respond more strongly to signals in the brain.
At the same time, the brain in Alzheimer’s disease already has protein buildup that triggers inflammation. The mutated cells may react more strongly to this situation, creating even more inflammation. This can harm nearby neurons, leading to their death and worsening the disease.
This new understanding opens the door to possible new ways to detect and treat Alzheimer’s disease. One idea is to use blood tests to look for these mutations. Since it is very difficult to study brain tissue in living people, a blood-based test could be a much easier way to identify those at higher risk.
Another important possibility is treatment. Since these mutations are similar to those seen in cancer, drugs that are already used to treat cancer might be useful for Alzheimer’s disease as well. This could speed up the development of new therapies.
However, there are still limitations to this research. The study shows a strong connection between these mutations and Alzheimer’s, but it does not fully prove that the mutations cause the disease. More studies are needed to confirm how these changes affect brain cells over time.
In addition, not all patients may have the same mutations, and Alzheimer’s disease likely has many different causes. This means that treatments may need to be tailored to each individual.
Overall, this study provides a new and important way to think about Alzheimer’s disease. It shows that changes in the immune cells of the brain, influenced by cancer-like mutations, may play a key role. While more research is needed, these findings bring hope for better diagnosis and treatment in the future.
If you care about brain health, please read studies about vitamin D deficiency linked to Alzheimer’s and vascular dementia, and higher magnesium intake could help benefit brain health.
For more information about brain health, please see recent studies about antioxidants that could help reduce dementia risk, and coconut oil could help improve cognitive function in Alzheimer’s.
